S&P 500   4,596.62 (+0.66%)
DOW   35,869.51 (+0.36%)
QQQ   381.33 (+0.90%)
AAPL   149.53 (+0.60%)
MSFT   308.78 (+0.21%)
FB   322.50 (-1.88%)
GOOGL   2,778.99 (+1.09%)
TSLA   1,066.36 (+4.05%)
AMZN   3,400.66 (+2.42%)
NVDA   245.91 (+6.15%)
BABA   172.41 (-2.13%)
NIO   42.12 (+2.06%)
CGC   13.36 (-1.55%)
GE   109.50 (+3.99%)
AMD   125.18 (+2.30%)
MU   69.36 (+0.87%)
T   25.66 (+0.08%)
F   16.02 (+0.13%)
ACB   7.08 (-1.39%)
DIS   172.14 (+0.08%)
PFE   43.12 (-0.07%)
BA   214.11 (+0.58%)
AMC   36.55 (-0.76%)
S&P 500   4,596.62 (+0.66%)
DOW   35,869.51 (+0.36%)
QQQ   381.33 (+0.90%)
AAPL   149.53 (+0.60%)
MSFT   308.78 (+0.21%)
FB   322.50 (-1.88%)
GOOGL   2,778.99 (+1.09%)
TSLA   1,066.36 (+4.05%)
AMZN   3,400.66 (+2.42%)
NVDA   245.91 (+6.15%)
BABA   172.41 (-2.13%)
NIO   42.12 (+2.06%)
CGC   13.36 (-1.55%)
GE   109.50 (+3.99%)
AMD   125.18 (+2.30%)
MU   69.36 (+0.87%)
T   25.66 (+0.08%)
F   16.02 (+0.13%)
ACB   7.08 (-1.39%)
DIS   172.14 (+0.08%)
PFE   43.12 (-0.07%)
BA   214.11 (+0.58%)
AMC   36.55 (-0.76%)
S&P 500   4,596.62 (+0.66%)
DOW   35,869.51 (+0.36%)
QQQ   381.33 (+0.90%)
AAPL   149.53 (+0.60%)
MSFT   308.78 (+0.21%)
FB   322.50 (-1.88%)
GOOGL   2,778.99 (+1.09%)
TSLA   1,066.36 (+4.05%)
AMZN   3,400.66 (+2.42%)
NVDA   245.91 (+6.15%)
BABA   172.41 (-2.13%)
NIO   42.12 (+2.06%)
CGC   13.36 (-1.55%)
GE   109.50 (+3.99%)
AMD   125.18 (+2.30%)
MU   69.36 (+0.87%)
T   25.66 (+0.08%)
F   16.02 (+0.13%)
ACB   7.08 (-1.39%)
DIS   172.14 (+0.08%)
PFE   43.12 (-0.07%)
BA   214.11 (+0.58%)
AMC   36.55 (-0.76%)
S&P 500   4,596.62 (+0.66%)
DOW   35,869.51 (+0.36%)
QQQ   381.33 (+0.90%)
AAPL   149.53 (+0.60%)
MSFT   308.78 (+0.21%)
FB   322.50 (-1.88%)
GOOGL   2,778.99 (+1.09%)
TSLA   1,066.36 (+4.05%)
AMZN   3,400.66 (+2.42%)
NVDA   245.91 (+6.15%)
BABA   172.41 (-2.13%)
NIO   42.12 (+2.06%)
CGC   13.36 (-1.55%)
GE   109.50 (+3.99%)
AMD   125.18 (+2.30%)
MU   69.36 (+0.87%)
T   25.66 (+0.08%)
F   16.02 (+0.13%)
ACB   7.08 (-1.39%)
DIS   172.14 (+0.08%)
PFE   43.12 (-0.07%)
BA   214.11 (+0.58%)
AMC   36.55 (-0.76%)
CVE:VGW

Valens GroWorks Stock Forecast, Price & News

C$3.10
+0.05 (+1.64 %)
(As of 12/18/2019)
Add
Today's Range
C$2.97
C$3.10
50-Day Range
C$3.10
C$3.10
52-Week Range
C$1.22
C$4.90
Volume306,310 shs
Average Volume622,710 shs
Market CapitalizationC$383.88 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive VGW News and Ratings via Email

Sign-up to receive the latest news and ratings for Valens GroWorks and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
CIK
N/A
Web
N/A
Phone
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
C$27.50 million
Cash Flow
C$0.57 per share
Book Value
C$0.98 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$383.88 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Valens GroWorks (CVE:VGW) Frequently Asked Questions

What stocks does MarketBeat like better than Valens GroWorks?

Wall Street analysts have given Valens GroWorks a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Valens GroWorks wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Valens GroWorks' stock price been impacted by Coronavirus?

Valens GroWorks' stock was trading at C$3.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VGW shares have increased by 3.3% and is now trading at C$3.10.
View which stocks have been most impacted by COVID-19
.

What other stocks do shareholders of Valens GroWorks own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Valens GroWorks investors own include (CGC), OrganiGram (OGI), The Green Organic Dutchman (TGOD), Aurora Cannabis (ACB), BlackBerry (BB), Dynavax Technologies (DVAX), Heat Biologics (HTBX), Drone Delivery Canada (TAKOF), VEON (VEON) and Vaxart (VXRT).

What is Valens GroWorks' stock symbol?

Valens GroWorks trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VGW."

How do I buy shares of Valens GroWorks?

Shares of VGW and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Valens GroWorks' stock price today?

One share of VGW stock can currently be purchased for approximately C$3.10.

How much money does Valens GroWorks make?

Valens GroWorks has a market capitalization of C$383.88 million and generates C$27.50 million in revenue each year.


This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.